Overall and progression-free survival with cabazitaxel in metastatic castration-resistant prostate cancer in routine clinical practice: the FUJI cohort.
- DOI
- 10.1038/s41416-019-0611-6
- Published
- 2019 Dec
- Container
- British journal of cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41416-019-0611-6,
title = {Overall and progression-free survival with cabazitaxel in metastatic castration-resistant prostate cancer in routine clinical practice: the FUJI cohort.},
author = {Rouyer M and Oudard S and Joly F and Fizazi K and Tubach F and Jove J and Lacueille C and Lamarque S and Guiard E and Balestra A and Droz-Perroteau C and Fourrier-Reglat A and Moore N and FUJI Investigators},
year = {2019},
journal = {British journal of cancer},
doi = {10.1038/s41416-019-0611-6},
url = {https://doi.org/10.1038/s41416-019-0611-6}
}RIS
TY - JOUR TI - Overall and progression-free survival with cabazitaxel in metastatic castration-resistant prostate cancer in routine clinical practice: the FUJI cohort. AU - Rouyer M AU - Oudard S AU - Joly F AU - Fizazi K AU - Tubach F AU - Jove J AU - Lacueille C AU - Lamarque S AU - Guiard E AU - Balestra A AU - Droz-Perroteau C AU - Fourrier-Reglat A AU - Moore N AU - FUJI Investigators PY - 2019 JO - British journal of cancer DO - 10.1038/s41416-019-0611-6 UR - https://doi.org/10.1038/s41416-019-0611-6 ER -
APA
M, R., S, O., F, J., K, F., F, T., J, J., C, L., S, L., E, G., A, B., C, D., A, F., N, M., & Investigators, F. (2019). Overall and progression-free survival with cabazitaxel in metastatic castration-resistant prostate cancer in routine clinical practice: the FUJI cohort.. British journal of cancer. https://doi.org/10.1038/s41416-019-0611-6
Source records
- pubmed · retrieved 2026-09-26T04:48:15.494Z